Friday, August 3, 2018

Shikiar Asset Management Inc. Has $691,000 Stake in Honeywell International Inc. (HON)

Shikiar Asset Management Inc. lowered its position in Honeywell International Inc. (NYSE:HON) by 9.9% during the second quarter, Holdings Channel reports. The institutional investor owned 4,800 shares of the conglomerate’s stock after selling 525 shares during the quarter. Shikiar Asset Management Inc.’s holdings in Honeywell International were worth $691,000 as of its most recent SEC filing.

Several other institutional investors have also recently modified their holdings of HON. CX Institutional purchased a new stake in Honeywell International during the 2nd quarter worth approximately $100,000. Wagner Wealth Management LLC purchased a new stake in Honeywell International during the 4th quarter worth approximately $101,000. Well Done LLC purchased a new stake in Honeywell International during the 1st quarter worth approximately $103,000. Jolley Asset Management LLC purchased a new stake in Honeywell International during the 2nd quarter worth approximately $104,000. Finally, Bruderman Asset Management LLC purchased a new stake in Honeywell International during the 1st quarter worth approximately $114,000. 74.81% of the stock is currently owned by hedge funds and other institutional investors.

Get Honeywell International alerts:

Shares of Honeywell International opened at $155.90 on Friday, according to MarketBeat Ratings. The company has a quick ratio of 1.11, a current ratio of 1.38 and a debt-to-equity ratio of 0.70. Honeywell International Inc. has a 12 month low of $134.50 and a 12 month high of $165.13. The company has a market cap of $116.51 billion, a price-to-earnings ratio of 20.45, a price-to-earnings-growth ratio of 1.83 and a beta of 1.03.

Honeywell International (NYSE:HON) last announced its quarterly earnings data on Friday, July 20th. The conglomerate reported $2.12 EPS for the quarter, beating the consensus estimate of $2.01 by $0.11. Honeywell International had a net margin of 3.88% and a return on equity of 31.46%. The business had revenue of $10.92 billion during the quarter, compared to analysts’ expectations of $10.80 billion. During the same period in the previous year, the business posted $1.80 EPS. The business’s quarterly revenue was up 8.3% compared to the same quarter last year. equities research analysts forecast that Honeywell International Inc. will post 8.14 earnings per share for the current year.

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, September 7th. Shareholders of record on Friday, August 17th will be paid a dividend of $0.745 per share. This represents a $2.98 annualized dividend and a yield of 1.91%. The ex-dividend date is Thursday, August 16th. Honeywell International’s payout ratio is 41.91%.

In other Honeywell International news, Director Linnet F. Deily sold 3,066 shares of Honeywell International stock in a transaction that occurred on Monday, July 30th. The shares were sold at an average price of $158.12, for a total transaction of $484,795.92. Following the completion of the sale, the director now directly owns 11,787 shares in the company, valued at approximately $1,863,760.44. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, insider Timothy O. Mahoney sold 114,489 shares of Honeywell International stock in a transaction that occurred on Friday, May 25th. The shares were sold at an average price of $150.20, for a total transaction of $17,196,247.80. Following the sale, the insider now owns 314,725 shares of the company’s stock, valued at $47,271,695. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 130,977 shares of company stock valued at $19,788,828. Company insiders own 1.33% of the company’s stock.

Several research firms have weighed in on HON. Stifel Nicolaus boosted their target price on shares of Honeywell International from $157.00 to $175.00 and gave the stock a “buy” rating in a research report on Monday, April 23rd. Barclays boosted their target price on shares of Honeywell International from $170.00 to $172.00 and gave the stock an “overweight” rating in a research report on Monday, April 23rd. Zacks Investment Research raised shares of Honeywell International from a “hold” rating to a “buy” rating and set a $169.00 target price on the stock in a research report on Monday, May 28th. ValuEngine raised shares of Honeywell International from a “hold” rating to a “buy” rating in a research report on Tuesday. Finally, Oppenheimer dropped their target price on shares of Honeywell International from $180.00 to $172.00 and set an “outperform” rating on the stock in a research report on Monday, April 30th. Two equities research analysts have rated the stock with a hold rating and sixteen have given a buy rating to the stock. The stock has an average rating of “Buy” and an average target price of $170.41.

Honeywell International Profile

Honeywell International Inc operates as a diversified technology and manufacturing company worldwide. It operates through four segments: Aerospace; Home and Building Technologies; Performance Materials and Technologies; and Safety and Productivity Solutions. The Aerospace segment supplies products, software, and services for aircraft and vehicles that it sells to original equipment manufacturers and other customers in various markets, including air transport, regional, business and general aviation aircraft, airlines, aircraft operators, defense and space contractors, and automotive and truck manufacturers.

See Also: Momentum Indicator: Relative Strength Index

Want to see what other hedge funds are holding HON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Honeywell International Inc. (NYSE:HON).

Institutional Ownership by Quarter for Honeywell International (NYSE:HON)

Thursday, August 2, 2018

Top Small Cap Stocks To Own Right Now

tags:CNR,ACHN,FCEL,PQ,

Zinc may not immediately come to mind as an important metal for the global economy, but its actually the fourth most common metal in use -�trailing only iron, aluminium and copper. That��s because zinc would�most commonly be used as an anti-corrosion agent and for galvanization (coating of iron or steel) plus for other�industrial purposes (e.g. used as pigments,�preservatives, propellants etc). Zinc�was�also one of the best performing metals in 2016 and the outlook remains strong due in part to a global supply deficit��� meaning there are opportunities in zinc even for small cap miners. �

This brings me to Kootenay Zinc Corp (OTCMKTS: KTNNF; CNSX: ZNK)�which is a Canadian mineral exploration and development company focused on discovering large-scale sedimentary-exhalative ("SEDEX") deposits. The Company is�presently targeting the Sully Property which�comprises 1,375 hectares located approximately 30 kilometres east of Kimberley, B.C., and overlies rocks of similar age and origin as those which host the world-class Sullivan deposit, owned by Teck Resources Ltd. Sullivan was discovered in 1892, and is known to be one of the largest SEDEX deposits in the world. Over its 100-year lifetime, Sullivan has produced approximately 150 million tonnes of ore, including approximately three hundred million ounces of silver, eight million tonnes of zinc and eight million tonnes of lead.�

Top Small Cap Stocks To Own Right Now: China Metro-Rural Holdings Limited(CNR)

Advisors' Opinion:
  • [By Shane Hupp]

    Wall Street analysts expect that Canadian National Railway (NYSE:CNI) (TSE:CNR) will announce $1.02 earnings per share (EPS) for the current quarter, according to Zacks Investment Research. Seven analysts have provided estimates for Canadian National Railway’s earnings, with the highest EPS estimate coming in at $1.06 and the lowest estimate coming in at $0.97. Canadian National Railway reported earnings per share of $1.00 in the same quarter last year, which would suggest a positive year over year growth rate of 2%. The company is expected to announce its next quarterly earnings results on Tuesday, July 24th.

  • [By Shane Hupp]

    Her Majesty the Queen in Right of the Province of Alberta as represented by Alberta Investment Management Corp cut its position in Canadian National Railway (NYSE:CNI) (TSE:CNR) by 21.1% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 1,956,400 shares of the transportation company’s stock after selling 522,300 shares during the period. Canadian National Railway accounts for about 1.7% of Her Majesty the Queen in Right of the Province of Alberta as represented by Alberta Investment Management Corp’s investment portfolio, making the stock its 7th biggest position. Her Majesty the Queen in Right of the Province of Alberta as represented by Alberta Investment Management Corp owned 0.27% of Canadian National Railway worth $184,215,000 at the end of the most recent reporting period.

  • [By Joseph Griffin]

    Shares of Canadian National Railway (TSE:CNR) (NYSE:CNI) have been given an average recommendation of “Buy” by the eleven research firms that are covering the firm, MarketBeat reports. One investment analyst has rated the stock with a hold recommendation and six have issued a buy recommendation on the company. The average 12-month price target among brokerages that have updated their coverage on the stock in the last year is C$109.36.

  • [By Stephan Byrd]

    Brokerages expect Canadian National Railway (NYSE:CNI) (TSE:CNR) to announce earnings of $1.03 per share for the current fiscal quarter, Zacks Investment Research reports. Eight analysts have issued estimates for Canadian National Railway’s earnings, with the highest EPS estimate coming in at $1.10 and the lowest estimate coming in at $0.97. Canadian National Railway reported earnings of $1.00 per share in the same quarter last year, which would indicate a positive year over year growth rate of 3%. The business is scheduled to issue its next quarterly earnings report on Tuesday, July 24th.

  • [By Max Byerly]

    Canadian National Railway (NYSE:CNI) (TSE:CNR) – Cormark raised their Q3 2018 earnings per share (EPS) estimates for Canadian National Railway in a research report issued to clients and investors on Tuesday, April 10th. Cormark analyst D. Tyerman now expects that the transportation company will post earnings per share of $1.15 for the quarter, up from their previous estimate of $1.14.

  • [By Max Byerly]

    Compass Capital Management Inc. bought a new position in Canadian National Railway (NYSE:CNI) (TSE:CNR) during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund bought 2,535 shares of the transportation company’s stock, valued at approximately $207,000.

Top Small Cap Stocks To Own Right Now: Achillion Pharmaceuticals Inc.(ACHN)

Advisors' Opinion:
  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Achillion Pharmaceuticals (ACHN)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    News articles about Achillion Pharmaceuticals (NASDAQ:ACHN) have trended somewhat positive this week, Accern Sentiment reports. The research firm ranks the sentiment of press coverage by analyzing more than twenty million blog and news sources in real-time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Achillion Pharmaceuticals earned a media sentiment score of 0.16 on Accern’s scale. Accern also gave news articles about the biopharmaceutical company an impact score of 46.941587509483 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the near term.

  • [By Ethan Ryder]

    Achillion Pharmaceuticals (NASDAQ:ACHN) – Research analysts at B. Riley reduced their FY2018 EPS estimates for shares of Achillion Pharmaceuticals in a research note issued to investors on Wednesday, May 2nd. B. Riley analyst M. Kumar now anticipates that the biopharmaceutical company will earn ($0.58) per share for the year, down from their previous estimate of ($0.55). B. Riley has a “Neutral” rating and a $3.50 price objective on the stock. B. Riley also issued estimates for Achillion Pharmaceuticals’ FY2019 earnings at ($0.64) EPS, FY2020 earnings at ($0.71) EPS, FY2021 earnings at ($0.70) EPS and FY2022 earnings at ($0.84) EPS.

Top Small Cap Stocks To Own Right Now: FuelCell Energy Inc.(FCEL)

Advisors' Opinion:
  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on FuelCell Energy (FCEL)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Paul Ausick]

    FuelCell Energy Inc. (NASDAQ: FCEL) posted an increase of 8% in short interest during the two-week period. Some 7.45 million shares were short as of May 31. The stock’s price was $1.76 at Monday’s market close, a spike of about 1.1% for the day, within a 52-week range of $1.08 to $2.49. Shares traded up about 2.5% in the two-week short interest period, and the number of days to cover rose from 14 to 17.

  • [By Logan Wallace]

    FuelCell Energy (NASDAQ: FCEL) and HRG Group (NYSE:HRG) are both oils/energy companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, valuation, risk, analyst recommendations, institutional ownership, earnings and profitability.

  • [By Paul Ausick]

    FuelCell Energy Inc. (NASDAQ: FCEL) posted a decrease of 25.7% in short interest during the period. Some 5.86 million shares were short as of April 30. The stock closed at $1.93 on Wednesday, up about 1.6% for the day, in a 52-week range of $0.80 to $2.49. Shares traded down about 7.8% in the short interest period, and days to cover rose from six to eight.

Top Small Cap Stocks To Own Right Now: Petroquest Energy Inc(PQ)

Advisors' Opinion:
  • [By Ethan Ryder]

    News headlines about Petroquest Energy (NYSE:PQ) have been trending somewhat positive recently, Accern Sentiment Analysis reports. Accern identifies negative and positive news coverage by reviewing more than 20 million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Petroquest Energy earned a coverage optimism score of 0.05 on Accern’s scale. Accern also gave news stories about the energy company an impact score of 47.638327846877 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the near future.

Wednesday, August 1, 2018

Will Colgate-Palmolive Announce a Growth Rebound This Week?

The consumer staples industry has been hampered by slow growth and rising costs that companies are struggling to pass along to consumers. Colgate Palmolive�(NYSE:CL) hasn't proven itself to be immune from these challenges. In fact, the market share leader in toothpaste and toothbrushes lowered its sales outlook last quarter, which helped the stock underperform the broader market through the first half of 2018.

Colgate has a chance to shift that dynamic when it posts second-quarter results on Friday, July 27. However, investors aren't expecting dramatic improvements in its operating trends.

A mother and daughter brushing teeth.

Image source: Getty Images.

Market share checkup

Colgate managed to accelerate sales growth up to 2% at the end of fiscal year 2017. Yet that success didn't carry over into the current year. Instead, sales inched higher by just 1.5% in the first quarter to trail management's expectations.

CEO Ian Cook said the period was "a challenging one as category growth remained soft in many markets around the world." Executives highlighted healthy volume gains in developed markets like the United States and Europe, but said emerging markets were much weaker.

The good news is, despite tough sales conditions in the industry, executives expect sales gains to speed up over the next few quarters. Thus, investors will be looking for Colgate to announce better organic growth results than its most recent 1.5% uptick.

The company will also update investors on its market share position, which should stay strong. At its last check-in Colgate revealed that it controlled 43.3% of the global toothpaste market and 32.6% of worldwide sales of manual toothbrushes.

Costs and prices

Faster growth might come at a price, though. For Colgate, this trade-off would show up in two key places. First, keep an eye on gross profit margin, which ticked down to 60.2% of sales from 60.3% last quarter. That figure isn't likely to rebound without stronger pricing trends than the flat result investors saw in the first quarter. If Colgate can't pass along rising raw material prices to its customers, then management's cost cutting efforts won't do much more than limit profitability declines.

Second, investors should watch for changes in operating profit margin, which will reflect the company's stepped-up advertising and marketing commitments. That metric dipped to 25.2% last quarter from 25.4% as the company boosted ad spending by 4% to $416 million. Cook said management plans to continue that marketing effort so that, with help from innovative product launches, sales growth trends will improve over the next few quarters.

Updated forecast

Finally, watch for an updated 2018 outlook that reflects the latest sales and profit trends. That forecast received a minor downgrade on both the top and bottom lines in late April. Regarding sales growth, management said they see organic revenue rising in the low single-digits whereas the prior forecast left open the possibility for mid-single-digit gains.

On profits, executives predicted low double-digit growth in per-share earnings for a slight decrease from their late January prediction. While it's possible that the 2018 forecast will rise due to a rebound in demand, the more likely scenario involves a steady, or even slightly deteriorating, outlook that follows the weak trends in the broader industry. As usual, investors can expect the earnings pinch to be muted this year, thanks to Colgate's dominant market position and its rock-solid finances.